Literature DB >> 3921613

Developmentally controlled expression of IL 2 receptors and of sensitivity to IL 2 in a subset of embryonic thymocytes.

C Hardt, T Diamantstein, H Wagner.   

Abstract

At various times of gestation murine fetal thymocytes were tested for IL 2 receptor (IL 2-R) and T cell differentiation antigen expression. The majority of 14 to 15 day fetal thymocytes were IL 2-R and Thy-1 antigen positive, yet negative for the Lyt and L3T4 marker. A subset of IL 2-R-positive fetal thymocytes could be induced by recombinant IL 2 to proliferate over at least 10 days. Growth of these proliferating cells could not be enhanced by syngeneic feeder cells nor suppressed by monoclonal anti-I-A or anti-I-E antibodies. No antigen-specific effector functions could be induced in the proliferating Thy-1, IL 2-R-positive cells. As a whole, the results suggest a developmentally controlled rather than antigen-induced expression of IL 2-R during embryogenesis of thymocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.

Authors:  P Comoli; R Maccario; D Montagna; M Labirio; M Zecca; R Clementi; F Bonetti; F Locatelli
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

2.  Developmental control of lymphokine gene expression in fetal thymocytes during T-cell ontogeny.

Authors:  S R Carding; E J Jenkinson; R Kingston; A C Hayday; K Bottomly; J J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors.

Authors:  M L Toribio; A de la Hera; J Borst; M A Marcos; C Márquez; J M Alonso; A Bárcena; C Martínez
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.